We provide Control Human Induced Pluripotent Stem (iPS) cells at low passages (p8). These pluripotent cells were generated from normal, female human peripheral blood mononuclear cells (PBMCs) using a Sendai virus reprogramming method. This method allows the transient expression of human transcription factors that initiate the reprogramming process. The resulting human iPS cells (hiPSCs) were selected using morphological criteria without the use of either fluorescent markers or drug selection.
These iPS cells have been tested for the expression of the pluripotency markers OCT4, SOX2, and SSEA4, and for normal female karyotype.
The ASE-9217 control human iPSC line can be used for CRISPR/Cas9 genome editing and differentiation to somatic lineages in vitro.
Fill out the contact form below and a team member will be in touch within one business day.
